The U.S. Food and Drug Administration (FDA) has accepted an investigational new drug (IND) application for XS-411, a stem cell-based therapy developed by Xellsmart for Parkinsons disease, clearing th… [+2874 chars]
Stem cell therapy for Parkinson’s disease approved for Phase 1 trials - Parkinson's News Today
The therapy utilizes induced pluripotent stem cells, a versatile type of cell that can be developed into nearly any other cell type.
By:Lila Levinson, PhD
Source:Parkinson's News Today
Published:
Related News
This Is the Vaccine Story RFK Jr. Doesn’t Want You to Hear - The Bulwark
The Trump administration says we should learn from other countries. Maybe they should have looked someplace besides Denmark.
The Bulwark•Jonathan Cohn
Close to 90% of Americans have silent heart disease, AHA says - NewsNation
The AHA acknowledged that Cardiovascular-Kidney-Metabolic syndrome (CKM) is a condition that involves a chain reaction inside the body.
Newsnationnow.com•Rob Taub
This Forgotten Cancer Vaccine’s Results Were So Unusual Scientists Revisited It 20 Years Later - SciTechDaily
New research suggests that a breast cancer vaccine developed decades ago may have triggered a lasting immune memory response that can now be significantly boosted by a newly developed antibody.
SciTechDaily